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Abstract
Purpose: To evaluate the ability and the utility of diffusion-weighted magnetic resonance imaging (MRI) with different 
‘b’ values to visualise benign and malignant lung lesions, and to determine which ‘b’ value (b = 300, 500, or 1000 s/mm2) 
was most useful in differentiating benign from malignant lung lesions.
Material and methods: A total of 100 patients (28 women, 72 men; mean age = 57.19 ± 13.44 years; age range = 20-83 
years). Diffusion-weighted imaging (DWI) was obtained with ‘b’ values of 300, 500, and 1000 s/mm². The signal 
intensity of lesions on DWI images was analysed, and the apparent diffusion coefficient (ADC) values of the lesions 
were calculated. MRI was performed in all patients after having presented at our department for thoracic computed 
tomography for various reasons. 
Results: A statistically significant difference in DWI signal scores was detected between benign and malignant lesions for 
all ‘b’ factors (p < 0.0001 for each). The sensitivity and specificity were 95% and 64%, respectively, when a score of 3 for 
b = 300 s/mm²; 90% and 69%, respectively, when a score of 3 for b = 500 s/mm²; and 84% and 74%, respectively, when 
a score of 3 for b = 1000 s/mm². ADC values showed significant differences between benign and malignant lesions for 
all ‘b’ factors (p < 0.0001 for each).
Conclusions: Using ‘b’ values of 300, 500, and 1000 s/mm², DWI signal intensity scores and ADC values are effective 
methods for the differential diagnosis of malignant and benign pulmonary lesions.
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Introduction
Lung cancer is a leading cause of cancer death; hence, the 
characterisation of pulmonary nodules or masses by non-
invasive methods is a major concern for radiologists and 
clinicians. Most pulmonary nodules share morphological 
similarities, and 25-39% of malignant nodules are assessed 
radiologically as benign [1]. Determining a radiological 
method that is accurate, as specific as possible, and mini-
mally invasive in order to differentiate between benign and 
malignant lung lesions is considered an important diag-
nostic issue.
In the current algorithms for diagnostic guidelines 
for lung pathologies, radiography, computed tomography 
(CT), and positron emission tomography are commonly 
available. Motion artefacts in magnetic resonance imaging 
(MRI) of the blocker software, the use of multiple chan-
nels can be received now displays the desired quality in 
the thorax and fast, thanks to new technologies such as 
parallel imaging sequences. Diffusion-weighted imaging 
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(DWI) is a noninvasive technique that reflects the random 
movement of water molecules (diffusion) in the tissues [2]. 
The sensitivity of DWI is regulated by different ‘b’ values. 
The ‘b’ value is a term defining the power of the diffu-
sion sensitiser gradient [3]. Detection of more signal loss 
with higher ‘b’ values indicates that diffusion is affected 
not only by the movement of the water molecules but also 
by tissue perfusion [4,5]. DWI and the apparent diffusion 
coefficient (ADC) values provide important additional in-
formation beyond that of MRI. To the best of our knowl-
edge, very few reports have described the application of 
DWI in the evaluation of pulmonary masses [6,7].
The aim of this study was to evaluate the role of DW 
MRI with various ‘b’ values, to visualise pulmonary lesions 
and to determine which ‘b’ value (300, 500, or 1000 s/mm²) 




This study was approved by our institutional review board, 
and informed consent was obtained from all patients. 
A total of 100 patients (28 women, 72 men; mean age, 57.19 
± 13.44 years; age range, 20-83 years) who had pulmonary 
nodules or masses that had a minimum nodule diameter 
of 1 cm were included in this study. MRI was performed 
in all patients after having presented at our department for 
thoracic CT for various reasons. In all 100 nodules/masses 
the final diagnoses were made histologically.
Magnetic resonance imaging protocol
All MRI examinations were performed using a com-
mercially available 1.5-Tesla MRI unit (Philips Medical 
Systems, Best, Netherlands) with a linearly polarised 
body coil. All patients were examined in the supine po-
sition. For each patient, the following were used for the 
T1-weighted images: T1- and T2-weighted turbo spin-
echo (TSE) images were taken in the axial plane. TR/TE, 
100 ms/11 ms; matrix, 256 × 128; section thickness, 
6 mm; section gap, 1 mm; field of view, 36 cm; flip angle, 
70°; number of signals acquired, 1. T2-weighted images 
were taken using respiratory gating. The following were 
used for the T2 images: TR/TE, 5000 ms/80 ms; matrix, 
320 × 224 echo train length, 17; section thickness, 6 mm; 
section gap, 1 mm; field of view, 36 cm; number of signals 
acquired, 2.
DWI were obtained with a single-shot echo-planar 
imaging sequence. DWI was performed with ‘b’ values of 
0, 300, 500, and 1000 s/mm². The following were used for 
DW images TR/TE, 5000 ms/100 ms; matrix, 128 × 128; 
section thickness, 8 mm; section gap, 1 mm; field of view, 
360 mm; R factor, 2; number of signals acquired, 4. The 
data acquisition time for the DW images was 28 seconds. 
All MR images were obtained during end-inspiration 
breath holding. Diffusion gradients were obtained in three 
planes (x, y, and z). ADC maps belonging to the isotropic 
images were created automatically by the device. The ADC 
values of the lesions were calculated in compliance with 
the ADC maps that were created in the second console 
of the MRI machine (View Forum R5.x, Philips Medical 
Systems).
Image analysis
All images and signal intensity data for the lesions on DWI 
with ‘b’ factors of 300, 500, and 1000 s/mm² were evaluated 
by two radiologists independently, who were blinded to the 
clinical data. Intensities were rated on a scale from 1 to 5, 
in which: 1 – no signal intensity; 2 – signal intensity be-
tween 1 and 3; 3 – signal intensity similar to thoracic spi-
nal cord intensity; 4 – over signal intensity than the spinal 
thoracic cord intensity; and 5 – much over signal intensity 
than the thoracic spinal cord intensity.
ADC measurements were performed by locating the 
region of interest (ROI) covering one-third of the lesions 
in accordance with the T2-weighted images by two radiolo-
gists. The ADC value was calculated automatically by lo-
cating three different ROIs in the lesion areas. The ROI was 
placed centrally, and the size of the ROI was kept as large 
as possible to cover at least two-thirds of the lesion while 
avoiding interference from the surrounding lung tissue, 
necrotic parts, and major blood vessels. The lowest of three 
values was used for statistical analysis. ADC maps of lung 
nodules were not available because of their susceptibility to 
artefacts. In this study, nodules with a diameter of 1 cm or 
larger were included. The diameter was calculated using the 
mean of the long- and short-axis diameters of nodules or 
masses on T1-weighted images.
Statistical analysis
The data were assessed using SPSS 15.0 and Sigma Stat 3.5 
software. Comparison of categorical variables was per-
formed by the exact method of Pearson’s c2 test. The Kol-
mogorov-Smirnov test was used to determine the nor-
mality of the distribution of the data. In variables showing 
normal and non-normal distributions in a comparison of 
the two groups, an independent two-sample t-test and the 
Mann-Whitney U-test were used, respectively. When the 
number of groups was greater than three, one-way variance 
analysis (one-way ANOVA) for the variables showing nor-
mal distributions, and Kruskal-Wallis analysis for variables 
showing non-normal distributions, were used. In multiple 
comparisons of those parameters that showed a difference 
in the one-way variance analysis, the Holm-Sidak test was 
used. To identify a suitable cut-off for the diagnostic tests, 
the receiver-operating characteristic (ROC) curve method 
was used. A p value < 0.05 was considered to indicate sta-
tistical significance.
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Results
The DWI signal intensity and ADC values of benign 
and malignant lesions in b = 1000 are summarised in Ta-
bles 1 and 2.
The DWI signal scores of benign lesions were 2.85 ± 
1.47, 2.70 ± 1.30, and 2.48 ± 1.28 with ‘b’ factors of 300, 
500, and 1000 s/mm², respectively (Figure 1). The DWI 
signal scores of malignant lesions were 4.62 ± 0.68, 4.54 
± 0.72, and 4.37 ± 0.79 with ‘b’ factors of 300, 500, and 
1000 s/mm², respectively (Figure 2). However, a statistical-
ly significant difference in DWI signal scores was detected 
between benign and malignant lesions for all ‘b’ factors 
(p < 0.0001 for each). A signal decrease in DWI was ob-
served in five malignant lesions: four adenocarcinomas 
and one squamous cell carcinoma. A signal increase in 
DWI was seen in 11 benign lesions: one Wegener’s granu-
lomatosis, four chronic active pus, one neurilemmoma, 
two organising pneumonia, one desquamative interstitial 
pneumonia, one extramedullary haematopoiesis, and one 
granulomatous lesion. We used the receiver operating 
characteristic (ROC) curve to evaluate the diagnostic ca-
pability of the five-point rank scale for differentiation be-
tween malignant and benign lesions. ROC analysis showed 
areas under the ROC curve of 0.825 for b = 300, 0.866 
for b = 500, and 0.869 for b = 1000 s/mm². ROC analy-
sis showed 95% confidence intervals (CI) of 0.738-0.893 
for b = 300, 0.785-0.926 for b = 500, and 0.785-0.926 for 
b = 1000 s/mm². The area under the curve was highest for 
b = 1000 s/mm². The sensitivity and specificity were, re-
spectively, 95% and 64% for a score of 3 for b = 300 s/mm², 
90% and 69% for a score of 3 for b = 500 s/mm², and 84% 
and 74% for a score of 3 for b = 1000 s/mm². However, 
the mean signal scores of DWI calculated with b = 300, 
500, and 1000 s/mm² showed no significant differences.
Apparent diffusion coefficient values showed signifi-
cant differences between benign and malignant lesions for 
all ‘b’ factors for benign lesions (2.17 ± 0.85, 1.94 ± 0.59, 
and 1.87 ± 0.60 mm²/s) and for malignant lesions (0.88 ± 
0.41, 0.95 ± 0.38, and 0.89 ± 0.32 mm²/s) with ‘b’ values 
of 300, 500, and 1000 s/mm², respectively (p < 0.0001 for 
each). The mean ADC value was 1.69 in the three adeno-
carcinomas, 1.51 in one adenocarcinoma, and 1.58 in one 
squamous cell carcinoma. The mean ADC values of two 
plasmacytoma cases were 0.62 and 1.68 for a ‘b’ factor of 
1000 s/mm², respectively. We used the receiver operat-
ing characteristic (ROC) curve to evaluate the diagnostic 
capability of the ADC values for differentiation between 
malignant and benign lesions. ROC analysis showed an 
area under the ROC curve of 0.898 for b = 300, 0.897 for 
b = 500, and 0.899 for b = 1000 s/mm². ROC analysis 
showed 95% CI of 0.823-0.949 for b = 300, 0.821-0.948 
for b = 500, and 0.823-0.950 for b = 1000 s/mm². ROC 
analysis of ADC values revealed that the area under the 
curve for b = 1000 s/mm² was highest. The sensitivity and 
specificity were, respectively, 93% and 82% when the value 
was 1.26 for b = 300 s/mm², 89% and 87% when the value 
was 1.19 for b = 500 s/mm², and 97% and 77% when the 
value was 1.49 for b = 1000 s/mm² (Figure 3). However, 
the mean ADC values calculated with b = 300, 500, or 
1000 s/mm² showed no statistically significant differences.
Table 1. Diffusion-weighted imaging (DWI) signal intensity and apparent 
diffusion coefficient (ADC) values of benign lesions in b = 1000 s/mm²
Lesion type DWI
(b = 1000 s/mm²)
ADC
(b = 1000 s/mm²)
Granulomatous lesion
(n = 9)
1.44 ± 0.44 1.96 ± 0.51
Chronic inflammation 
(n = 8)
2.00 ± 0.75 1.96 ± 0.30
Chronic active inflammation 
(n = 6)
4.00 ± 0.89 1.35 ± 0.63
Organizing pneumonia (n 
= 5)
2.60 ± 1.34 1.88 ± 0.53
Wegener’s granulomatosis 
(n = 2)








pneumonia (n = 1)
4.00 1.78
Extramedullary 
hematopoiesis (n = 1)
4.00 0.63





pneumonia (n = 1)
2.00 1.78
Schwannoma (n = 1) 5.00 2.27
Tuberculosis (n = 1) 2.00 1.87
Table 2. Diffusion-weighted imaging (DWI) signal intensity and apparent 
diffusion coefficient (ADC) values of malignant lesions in b = 1000 s/mm²
Lesion type DWI
(b = 1000 s/mm²)
ADC
(b = 1000 s/mm²)
Adenocarcinoma (n = 25) 4.33 ± 0.90 0.96 ± 0.41
Squamous cell carcinoma (n = 19) 4.46 ± 0.66 0.91 ± 0.22
Metastases (n = 5) 4.40 ± 0.89 1.09 ± 0.35
Small cell carcinoma (n = 4) 5.00 ± 0.00 0.57 ± 0.12
Large cell carcinoma (n = 2) 5.00 ± 0.00 0.75 ± 0.40
Malignant thymoma (n = 2) 5.00 ± 0.00 0.55 ± 0.10
Plasmacytoma (n = 2) 3.00 ± 0.00 0.85 ± 0.32
Malignant lymphoma (n = 1) 4.00 0.72
Mesothelioma (n = 1) 5.00 0.92
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Figure 1. A 73-year-old man with chronic inflammation in the right lung. 
A) T2-weighted image shows a slightly hyperintense mass in the right lung. 
B-D) The lesion showed hypo signal intensity compared with the normal 
spinal cord on diffusion-weighted images with three ‘b’ values (b = 300, 
500, and 1000, respectively). E-G) Apparent diffusion coefficient values are 
2.29 × 10–3 mm2/s, 2.13 × 10–3 mm2/s and 1.98 × 10–3 mm2/s in b = 300, 
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Figure 2. A 57-year-old man with a small-cell carcinoma in the left lung. 
A) T2-weighted image shows a hyperintense mass in the left lung. 
B-D) The lesion showed hyper signal intensity compared with the normal 
spinal cord on diffusion-weighted images with three ‘b’ values (b = 300, 
500, and 1000, respectively). E-G) Apparent diffusion coefficient values are 
0.64 × 10–3 mm2/s, 0.53 × 10–3 mm2/s and 0.65 × 10–3 mm2/s in b = 300, 






This study used different ‘b’ values for malignant-benign dif-
ferentiation of lung masses and found two significant results. 
The first is that the DWI signal score had high sensitivity 
and specificity for benign-malignant lung lesion differenti-
ation. As a result, DWI is a useful tool for benign-malignant 
nodule differentiation. The second result is that a significant 
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Figure 3. ROC analysis for critical apparent diffusion coefficient values in 
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difference was found for benign-malignant lung lesion dif-
ferentiation using ADC. In other words, ADC can be used 
for benign-malignant lesion differentiation.
The b = 1000 value contribution to DWI signal intensity 
for malignant-benign differentiation of lung masses with 
a threshold signal intensity score of 3 was used in two dif-
ferent studies. A study of 51 patients and 54 lesions by Satoh 
et al. [8] found 89% sensitivity, 61% specificity, and an area 
under the ROC curve of 0.87. A study carried out by Çakır 
et al. [7] included 46 patients with 48 lesions and found 
sensitivity of 93.3%, specificity of 88.9%, and an area under 
the ROC curve of 0.92. In our study, we used three different 
‘b’ values of 300, 500, and 1000, and with a signal score of 3, 
there was no difference found in the sensitivity, specificity, 
or area under the ROC curve. However, the highest area 
under the ROC curve was found for b = 1000 with an area 
of 0.87, which is a finding that is similar to those of previ-
ous studies. Contrarily, in our study, the used moderate and 
low ‘b’ values had similar sensitivity and specificity rates to 
b = 1000. DWI is used with increasing frequency for lung 
pathologies, although there is still no standardised ‘b’ val-
ue (s/mm²) for thorax applications. Studies have generally 
used a relatively high ‘b’ value (1000). Additionally, there 
are research studies available on lung cancer diffusion char-
acteristics that have obtained very good image quality using 
relatively low ‘b’ values (68/577, 0/500) [9-11]. However, to 
reduce T2 glare and intravoxel perfusion effects, high ‘b’ 
values should be chosen. High ‘b’ values reduce SNR and 
reveal anatomic disruption.
Histologically, well-differentiated adenocarcinoma 
grow without disrupting the lung architecture and are 
sourced in the normal cycle of cylindrical cells in the 
airway walls before alveolus. Poorly differentiated ade-
nocarcinoma and other lung tumours develop outside of 
the normal cycle of cells and form large expansive solid 
masses compressing their surroundings. As a result, the 
cellularity of well-differentiated tumours is lower than 
that of poorly differentiated adenocarcinoma and other 
lung tumours [9]. In our study, diffusion restriction was 
not observed in four adenocarcinoma cases or one squa-
mous cell carcinoma case, with ADC values higher than 
in malignant masses. This situation is linked to the cases 
demonstrating well-differentiated tumours. Extramedul-
lary plasmacytoma has the best prognosis among the plas-
ma cell neoplasms. However, 10-40% of cases progress to 
develop multiple myeloma [12]. In our study, in neither 
of the two plasmacytoma cases was diffusion restricting. 
This is linked to the cellularity of plasmacytoma being low 
and well-differentiated. It is difficult to interpret non-solid 
neoplasms and active inflammatory pulmonary nodules 
using the DWI signal intensities. Differences in signal 
intensity reflect histopathological differences with malig-
nant tumours that are generally hypercellular with large 
cells. Despite the fact that lung abscesses and active tu-
berculosis are benign pulmonary nodules, they contain 
very few inflammatory cells, and, as a result, high signal 
intensity may be observed [8]. In our study, DWI signal 
increase was observed for 11 benign lesions. Of these, one 
case had a schwannoma. This is linked to the clear hy-
perintensity of schwannoma on T2 due to the T2 effect. 
The signal increase for the other 10 lesions (four chronic 
active infection cases, two OP cases, one Wegener’s gran-
ulomatosis, one desquamative interstitial pneumonia, one 
extramedullary haematopoiesis, and one granulomatous 
lesion) is linked to greater cellularity.
In a study of 18 benign and 30 malignant lesions using 
the b = 1000 value, Çakır et al. [7] found that the ADC val-
ue for benign lesions was 2.423 ± 1.299 × 10-3 mm²/s, and 
for malignant lesions it was 1.185 ± 0.236 × 10-3 mm²/s. 
In a study using the b = 500 value for 12 benign and 54 
malignant lesions, Liu et al. [10] found that the ADC value 
for benign lesions was 1.64 ± 0.41 × 10-3 mm²/s, and for 
malignant lesions it was 1.25 ± 0.32 × 10-3 mm²/s. In our 
study, the ADC values for benign lesions using b = 300, 
b = 500, and b = 1000 were 2.17 ± 0.85, 1.94 ± 0.59, and 
1.87 ± 0.60, respectively. The ADC values for malignant 
lesions were 0.88 ± 0.41, 0.95 ± 0.38, and 0.89 ± 0.32 for 
b = 300, b = 500, and b = 1000, respectively. For both groups 
in which ADC values were measured at b = 300, b = 500, 
and b = 1000, we found a statistical difference that was 
similar to the findings of previous studies (p < 0.05). 
Çakır et al. [7] found 87% sensitivity and 89% specificity 
for the ADC threshold value of 1.5 using a ROC analysis 
with b = 1000. Liu et al. [10] found 83% sensitivity and 
74% specificity for a threshold value of 1.4 with b = 500. 
The results of ADC mapping from ROC analysis in our 
study found that the sensitivity and specificity values for 
the b = 300 threshold of 1.26 were 93% and 82%, b = 500 
threshold 1.19 were 89% and 87%, and b = 1000 threshold 
1.49 were 97% and 77%, respectively. These values are in 
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accordance with the literature, with the highest area under 
the ROC curve for b = 1000. However, low ‘b’ values (500) 
have been used in the differentiation of post-obstructive 
atelectasis with lung cancer [13]. When low ‘b’ values are 
used, it has been reported that ADC values are found to be 
higher. In a study using low ‘b’ values in a phantom appli-
cation, Matoba et al. obtained diffusion imaging in acetone 
and distilled water and measured the ADC values. Because 
their identified values were higher than presented in the 
literature for defined values for acetone and distilled water, 
the researchers proposed that this may have been due to 
the use of a low ‘b’ value because the tissue perfusion and 
T2 time directly affect ADC values. Thus, increasing the ‘b’ 
value reduces the T2 effect on imaging. In contrast, very 
high (< 1200) ‘b’ values are suggested to cause significant 
reduction in image quality due to shortened T2 time [9,11].
One of our study’s limitations is that it did not include 
lesions that were smaller than 1 cm in diameter. Such 
small lesions were not included in consideration of sus-
ceptibility artefacts due to the fact that air in the lungs 
and movement artefacts in lower zone and paracardiac 
localised lesions cause incorrect ADC measurements.
In conclusion, both DWI signal intensity scores and 
ADC values may be useful for the differentiation of be-
nign and malignant lung lesions at all ‘b’ values. However, 
the value of DW-MRI in differentiating between patholog-
ical types of benign and malignant lesions needs further 
study.
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